R 0002/15 (Right to be heard/EURO-CELTIQUE) of 21.11.2016
- European Case Law Identifier
- ECLI:EP:BA:2016:R000215.20161121
- Date of decision
- 21 November 2016
- Case number
- R 0002/15
- Petition for review of
- T 1938/09 2014-10-02
- Application number
- 98906678.2
- IPC class
- A61K 9/70A61K 31/485A61F 13/00
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen and members (B)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- R 0002/15 Notice of withdrawal/EURO-CELTIQUE 2015-10-21
- Abstracts for this decision
- -
- Application title
- Sustained analgesia achieved with transdermal delivery of buprenorphine
- Applicant name
- EURO-CELTIQUE S.A.
- Opponent name
- Hexal AG
Acino AG - Board
- -
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 112a(2)(c)European Patent Convention Art 112a(2)(d)European Patent Convention Art 113(1)European Patent Convention R 104(b)
- Keywords
- Fundamental violation of right to be heard (no) - Failure to decide on request (no) - Petition for review clearly unallowable.
- Catchword
- -
Order
For these reasons it is decided that:
The petition for review is unanimously rejected as clearly unallowable.